Evidence map›Paper›PMID 31695722›Full record

ArticleFrontiers in genetics2019

A Novel Compound Heterozygous

Hong Chen, Ke Yuan, Bingtao Zhang, Zexiao Jia, Chun Chen, Yilin Zhu, Yaping Sun, Hui Zhou, Wendong Huang, Li Liang and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Frontiers in genetics · 2022
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Hong ChenDepartment of Pediatrics, The First Affiliated Hospital, College of Medicine Zhejiang University, Hangzhou, China.
Ke YuanDepartment of Pediatrics, The First Affiliated Hospital, College of Medicine Zhejiang University, Hangzhou, China.
Bingtao ZhangCollege of Life Science, Zhejiang University, Hangzhou, China.
Zexiao JiaCollege of Life Science, Zhejiang University, Hangzhou, China.
Chun ChenDepartment of Pediatrics, The First Affiliated Hospital, College of Medicine Zhejiang University, Hangzhou, China.
Yilin ZhuDepartment of Pediatrics, The First Affiliated Hospital, College of Medicine Zhejiang University, Hangzhou, China.
Yaping SunCollege of Life Science, Zhejiang University, Hangzhou, China.
Hui ZhouCollege of Life Science, Zhejiang University, Hangzhou, China.
Wendong HuangDepartment of Diabetes Complications and Metabolism, The Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, United States.
Li LiangDepartment of Pediatrics, The First Affiliated Hospital, College of Medicine Zhejiang University, Hangzhou, China.
Qingfeng YanDepartment of Pediatrics, The First Affiliated Hospital, College of Medicine Zhejiang University, Hangzhou, China.
Chunlin WangDepartment of Pediatrics, The First Affiliated Hospital, College of Medicine Zhejiang University, Hangzhou, China.
Zhejiang University · CNCity Of Hope National Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

17α-hydroxylase/17,20-lyase deficiencycongenital adrenal hyperplasiaCYP17A1 generhabdomyolysisvariant

Identifiers

PMID31695722
PMCPMC6817513
OpenAlexW2981973161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.